These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 3879416)

  • 1. Evaluation of early diagnostic criteria including HLA-B27 for ankylosing spondylitis in a follow-up study.
    Zeidler H; Mau R; Mau W; Freyschmidt J; Majewski A; Deicher H
    Z Rheumatol; 1985; 44(6):249-53. PubMed ID: 3879416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ankylosing spondylitis (Bechterew) and tissue antigen HLA-B 27. I. Diagnostic value of HLA-typing].
    Gerber N; Ambrosini GC; Böni A; Ossola A; Wagenhäuser FJ; Fehr K; von Felten A
    Z Rheumatol; 1977; 36(7-8):219-23. PubMed ID: 919797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup.
    Mau W; Zeidler H; Mau R; Majewski A; Freyschmidt J; Stangel W; Deicher H
    J Rheumatol; 1988 Jul; 15(7):1109-14. PubMed ID: 3262757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of patients with spondyloarthritides and HLA-B27 positive antigen.
    Glasnović M; Bosnjak I; Sram M; Vranjes Z; Vcev A; Dobrosević B; Petricević JS; Horvatić E; Orkić Z; Tadzić R; Soldo A; Sisljagić D; Dinjar K
    Coll Antropol; 2011 Jun; 35(2):397-402. PubMed ID: 21755709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HLA-B27 in Bechterew's disease].
    Ulvestad E
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1317-22. PubMed ID: 10868094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B27 as a diagnostic screening tool in chronic low back pain.
    Sandström J; Andersson GB; Rydberg L
    Scand J Rehabil Med; 1984; 16(1):27-8. PubMed ID: 6231721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early diagnostic criteria of ankylosing spondylitis in patients with acute anterior uveitis].
    Hoffmann A; Brunner R; Barth A; Dietlein M; Gluch J; Hendricks C; Steffen HM
    Fortschr Ophthalmol; 1990; 87(6):560-1. PubMed ID: 2086393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of HLA-B27 in the diagnosis of ankylosing spondylitis: positive and negative predictive value and the probability ratio of diseases].
    Ferraz MB; Sesso R; Atra E
    Rev Paul Med; 1990; 108(4):153-6. PubMed ID: 2095616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ankylosing spondylitis without HLA B27.
    Van der Linden JM; De Ceulaer K; Van Romunde LK; Cats A
    J Rheumatol Suppl; 1977; 3():54-6. PubMed ID: 266598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the HLA B27 test in Auckland.
    Thomas MG; Hart HH; Grigor RR; Gow PJ; Moore TE
    N Z Med J; 1984 Oct; 97(765):686-8. PubMed ID: 6333007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27,B44.
    Purrmann J; Zeidler H; Bertrams J; Juli E; Cleveland S; Berges W; Gemsa R; Specker C; Reis HE
    J Rheumatol; 1988 Nov; 15(11):1658-61. PubMed ID: 3266250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis.
    Feldtkeller E; Khan MA; van der Heijde D; van der Linden S; Braun J
    Rheumatol Int; 2003 Mar; 23(2):61-6. PubMed ID: 12634937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of early diagnostic criteria for ankylosing spondylitis in a 10 year follow-up.
    Mau W; Zeidler H; Mau R; Majewski A; Freyschmidt J; Stangel W; Deicher H
    Z Rheumatol; 1990; 49(2):82-7. PubMed ID: 2140920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B27 testing in ankylosing spondylitis: an analysis of the pretesting assumptions.
    Baron M; Zendel I
    J Rheumatol; 1989 May; 16(5):631-4; discussion 634-6. PubMed ID: 2526875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens in vertebral ankylosing hyperostosis (Forestier's disease).
    Dostál C; Ivasková E; Hána I; Sváb V
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):98-102. PubMed ID: 6602164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of HLA antigens A and B and their cross reactions in B27-negative ankylosing spondylarthritis].
    Dreyfus P; Geay D; Cambon H; Daupleix D
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):269-72. PubMed ID: 6610919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of the HLA-B27 test in rheumatic diseases. A current perspective.
    Khan MA
    Arch Intern Med; 1980 Feb; 140(2):177-80. PubMed ID: 6986127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in pacemaker-treated patients. A follow-up study of the impact of HLA B27 and associated rheumatic disorders.
    Bergfeldt L; Allebeck P; Edhag O
    Acta Med Scand; 1987; 222(4):293-9. PubMed ID: 3501228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of HLA B27 antigen in Indian patients of ankylosing spondylitis and other autoimmune diseases.
    Kankonkar SR; Raikar SC; Joshi SV; Tijoriwala SJ
    J Assoc Physicians India; 1998 Apr; 46(4):345-50. PubMed ID: 11273314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of HLA associated disease: ankylosing spondylitis.
    Hammoudeh M; Khan MA
    J Rheumatol; 1983 Apr; 10(2):301-4. PubMed ID: 6602883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.